Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016–2022)
Background Male breast cancer (BC) is rare, accounting to approximately 1% of all breast cancers worldwide. Patients often present with advanced disease, contributing to poor outcomes. This study aimed to estimate two-year overall survival (OS) and identify clinicopathological and health-system–related predictors of su...